Yayınlar & Eserler

Yayın Ağı
Makaleler 21
Tümü (21)
SCI-E, SSCI, AHCI (21)
SCI-E, SSCI, AHCI, ESCI (21)
Scopus (20)

1. Development, Validation and Application of an RP-HPLC Method for the Determination of Reproxalap in Cyclodextrin Inclusion Complexes and an In Situ Ocular Hydrogel

Ceylan R., AYTEKİN E., Polat H. K., KAPLAN O., ÇELEBİER M., Pehlivan S. B.
Pharmaceutics , cilt.18, sa.9, 2026 (SCI-Expanded, Scopus)

2. Assessment of intranasal permeability and pharmacological activity of glyburide-loaded nanosuspension formulation for Alzheimer's disease

Gungor D., Muratoglu S., AYTEKİN E., REÇBER T., TELLİ G., AKDAĞ ÇAYLI Y., et al.
JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.115, sa.2, 2026 (SCI-Expanded, Scopus)

3. Preclinical evaluation of thymoquinone and black cumin seed oil formulations for experimental dry eye disease in rats: Comparative efficacy and safety per ARRIVE

DİKMETAŞ Ö., ARSLAN E., AYTEKİN E., Tatli-Cankaya I. İ., Pehlivan S. B., FIRAT A., et al.
Molecular Vision , cilt.32, ss.155-167, 2026 (SCI-Expanded, Scopus)

4. From nature to nanoscale: advances, challenges, and preclinical translation of nanofiber drug delivery systems containing plant-derived active ingredients

Polat H. K., Turanlı Y., KURT N., GÖZCÜ S., Tunçel E., Bacanak H., et al.
Journal of the Science of Food and Agriculture , 2026 (SCI-Expanded, Scopus)

5. Dual-action nanotherapy: Temozolomide-loaded, anti-PD-L1 scFv-functionalized lipid nanocarriers for targeted glioblastoma therapy

AYTEKİN E., Maksoud S., Tannous B. A., Pehlivan S., Badr C. E.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.213, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Optimizing riboflavin delivery with co-crystal and in situ hydrogel formulations for management of keratoconus: A comprehensive investigation with in vitro, ex vivo and in vivo studies

AYTEKİN E., Kaya M. Z., POLAT H. K., ÇAKMAK H. B., ÇELEBİER M., PALASKA E., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.674, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Optimization of Glyburide-Loaded Nanosuspensions via Ball Milling and Homogenization Techniques: A Central Composite Design Approach for Enhanced Solubility

Gungor D., AYTEKİN E., AKDAĞ ÇAYLI Y., ŞAHİN S., GÜLSÜN İNAL T.
CURRENT PHARMACEUTICAL DESIGN , cilt.31, sa.5, ss.377-390, 2025 (SCI-Expanded, Scopus)

8. Formulation of hesperidin-loaded in situ gel for ocular drug delivery: a comprehensive study

GÖZCÜ S., Polat H. K., Gültekin Y., ÜNAL S., KARAKUYU N. F., Şafak E. K., et al.
Journal of the Science of Food and Agriculture , cilt.104, sa.10, ss.5846-5859, 2024 (SCI-Expanded, Scopus)

9. Harnessing silk fibroin microparticles for metformin delivery: A novel approach to treating corneal neovascularization

Polat H. K., AYTEKİN E., KARAKUYU N. F., Çaylı Y., ÇALAMAK S., Demirci N., et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.96, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Gingerol containing polymeric nanofibers: a healing touch for accelerated wound recovery

Polat H. K., GÖZCÜ S., ÜNAL S., Pacaci T., AYTEKİN E., KARAKUYU N. F., et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.50, sa.7, ss.706-719, 2024 (SCI-Expanded, Scopus)

11. Formulation Development of Dual Drug-Loaded Thermosensitive Ocular In Situ Gel Using Factorial Design

Polat H. K., Arslan A., ÜNAL S., HAYDAR M. K., AYTEKİN E., GÖZCÜ S., et al.
Journal of Pharmaceutical Innovation , cilt.18, sa.2, ss.768-788, 2023 (SCI-Expanded, Scopus)

12. Formulation development of Lornoxicam loaded heat triggered ocular in-situ gel using factorial design

Polat H. K., ÜNAL S., AYTEKİN E., KARAKUYU N. F., PEZİK E., HAYDAR M. K., et al.
Drug Development and Industrial Pharmacy , cilt.49, sa.9, ss.601-615, 2023 (SCI-Expanded, Scopus)

13. Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers: In Vitro and Ex Vivo Evaluation

POLAT H. K., Kurt N., AYTEKİN E., AKDAĞ ÇAYLI Y., Pehlivan S., ÇALIŞ S.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS , cilt.38, sa.6, ss.412-423, 2022 (SCI-Expanded, Scopus)

14. Novel Drug Delivery Systems to Improve the Treatment of Keratitis

POLAT H. K., Kurt N., AYTEKİN E., Pehlivan S. B., ÇALIŞ S.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS , cilt.38, sa.6, ss.376-395, 2022 (SCI-Expanded, Scopus)

15. Corneal cross-linking approaches on keratoconus treatment

AYTEKİN E., Pehlivan S. B.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.63, 2021 (SCI-Expanded, Scopus)

16. Design of ocular drug delivery platforms and in vitro - in vivo evaluation of riboflavin to the cornea by non-interventional (epi-on) technique for keratoconus treatment

AYTEKİN E., ÖZTÜRK N., Vurla İ., POLAT H. K., Cakmak H. B., ÇALIŞ S., et al.
Journal of Controlled Release , cilt.324, ss.238-249, 2020 (SCI-Expanded, Scopus)

17. Development of besifloxacin HCl loaded nanofibrous ocular inserts for the treatment of bacterial keratitis: In vitro, ex vivo and in vivo evaluation

POLAT H. K., Pehlivan S. B., Ozkul C., ÇALAMAK S., Ozturk N., AYTEKİN E., et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS , cilt.585, 2020 (SCI-Expanded, Scopus)

18. Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections.

TIMUR S. S., ŞAHIN A., AYTEKIN E., ÖZTÜRK N., POLAT K., TEZEL N., et al.
Pharmaceutical development and technology , cilt.23, ss.301-310, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

19. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules

Yildiz S., AYTEKİN E., Yavuz B., Pehlivan S. B., VURAL İ., UNLU N.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.23, sa.5, ss.488-495, 2018 (SCI-Expanded, Scopus) Creative Commons License

20. Nanoscience in Targeted Brain Drug Delivery

ÇETİN M., AYTEKİN E., YAVUZ B., Bozdag-Pehlivan S.
NANOTECHNOLOGY METHODS FOR NEUROLOGICAL DISEASES AND BRAIN TUMORS: DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER , ss.117-147, 2017 (SCI-Expanded)

21. Formulation studies for mirtazapine orally disintegrating tablets

YILDIZ S., AYTEKİN E., Yavuz B., Pehlivan S., UNLU N.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY , cilt.42, sa.6, ss.1008-1017, 2016 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 12

1. Kuru Göz Hastalığının Tedavisinde Timokinon ve Çörek Otu Formülasyonları Uygulamasının Etkinliğinin Histopatolojik Olarak İncelenmesi

FIRAT A., DİKMETAŞ Ö., PEHLİVAN S., KOCABEYOĞLU S., İRKEÇ M. T., AYTEKİN E., et al.
22. Ulusal Anatomi Kongresi, Ankara, Türkiye, 13 - 17 Ekim 2021, (Özet Bildiri)

2. Ex-Vivo And In-Vivo Evaluation of Riboflavin Containing Solid Lipid Nanoparticles For The Treatment Of Keratoconus Disease

AYTEKİN E., PEHLİVAN S., ÇALIŞ S.
8th BBBB International Conference on Pharmaceutical Sciences, Türkiye, 14 - 16 Ekim 2019

3. In Vitro Evaluation of Ocular Insert Formulations Contaning Besifloxacin HCl

POLAT H. K., ÇALAMAK S., AYTEKİN E., PEHLİVAN S., ULUBAYRAM K., ÇALIŞ S.
8th BBBB International Conference on Pharmaceutical Sciences, Türkiye, 14 - 16 Ekim 2019

4. Development of Besifloxacin HCl Loaded Insert Formulations for the Treatment of Bacterial Keratitis

POLAT H. K., ÇALAMAK S., AYTEKİN E., PEHLİVAN S., ULUBAYRAM K., ÇALIŞ S.
8th BBBB International Conference on Pharmaceutical Sciences, Türkiye, 14 - 16 Ekim 2019

5. Fluorescence Labeled Nanostructured Lipid Carriers: Uptake by RG2 Glioma Cells

TEKE B., ÇAKIR AKTAŞ C., AYTEKİN E., PEHLİVAN S., MUT AŞKUN M.
8th BBBB, 14 - 16 Ekim 2019, (Özet Bildiri)

6. Investigation of Riboflavin and Riboflavin-5-Phosphate Sodium Release from Ocular Hydrogels

AYTEKİN E., PEHLİVAN S., ÇALIŞ S.
12th International Symposium on Pharmaceutical Sciences, Türkiye, 26 - 29 Haziran 2018, (Özet Bildiri)

7. Development of Solid Lipid Nanoparticles Containing Riboflavin By Factorial Design

AYTEKİN E., PEHLİVAN S., ÇALIŞ S.
European Federation for Pharmaceutical Sciences – EUFEPS Annual Meeting 2018, Yunanistan, 24 - 26 Mayıs 2018, (Özet Bildiri)

8. Development and Characterization Of Thermosensitive Hydrogel Systems Containing Riboflavin-5 Phosphate Sodium

AYTEKİN E., PEHLİVAN S., ÇALIŞ S.
2nd International Gazi Pharma Symposium Series, Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

9. IN VITRO PERMEATION STUDY FOR ORALLY DISINTEGRATINGTABLETS CONTAINING MIRTAZAPINE

yıldız s., AYTEKİN E., YAVUZ B., PEHLİVAN S., VURAL İ., Ünlü N.
2nd İnternational Gazi Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri)

10. Development of Electrospun Nanofiber-Based Implants Coated with Different Polymers for Topical Ocular Therapy

POLAT H. K., ÇALAMAK S., AYTEKİN E., PEHLİVAN S., ULUBAYRAM K., ÇALIŞ S.
The 22nd Biomedical Science and Technology Symposium, 12 - 14 Mayıs 2017, (Özet Bildiri)

11. Dexamethasone Loaded Electrospun Nanofiber Based Implants for Topical Ocular Therapy

POLAT H. K., ÇALAMAK S., AYTEKİN E., PEHLİVAN S., ULUBAYRAM K., ÇALIŞ S.
18th International Pharmaceutical Technology Symposium, 18 - 21 Eylül 2016, (Tam Metin Bildiri)

12. Effects of Different Fillers and Disintegrants on Mirtazapine Orally Disintegrating Tablet caharacteristics

Yıldız S., AYTEKİN E., YAVUZ B., PEHLİVAN S., Ünlü N.
GPSS 2015, 12 - 15 Kasım 2015, (Özet Bildiri)
Metrikler

Yayın

37

Yayın (WoS)

21

Yayın (Scopus)

20

Atıf (WoS)

154

H-İndeks (WoS)

7

Atıf (Scopus)

241

H-İndeks (Scopus)

7

Proje

10

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 15: AMAÇ 15: KARASAL YAŞAM